GT200500027A - Derivados de tetrahidroisoquinolinilo de quinazolina e isoquinolina - Google Patents
Derivados de tetrahidroisoquinolinilo de quinazolina e isoquinolinaInfo
- Publication number
- GT200500027A GT200500027A GT200500027A GT200500027A GT200500027A GT 200500027 A GT200500027 A GT 200500027A GT 200500027 A GT200500027 A GT 200500027A GT 200500027 A GT200500027 A GT 200500027A GT 200500027 A GT200500027 A GT 200500027A
- Authority
- GT
- Guatemala
- Prior art keywords
- tetrahydroisoquinolinilo
- isoquinolina
- quinazolina
- derivatives
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000000626 neurodegenerative effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54556504P | 2004-02-18 | 2004-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200500027A true GT200500027A (es) | 2005-10-24 |
Family
ID=34910729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200500027A GT200500027A (es) | 2004-02-18 | 2005-02-17 | Derivados de tetrahidroisoquinolinilo de quinazolina e isoquinolina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7268142B2 (enExample) |
| EP (1) | EP1723134A2 (enExample) |
| JP (1) | JP2007523152A (enExample) |
| AR (1) | AR047682A1 (enExample) |
| BR (1) | BRPI0507839A (enExample) |
| CA (1) | CA2556413A1 (enExample) |
| DO (1) | DOP2005000022A (enExample) |
| GT (1) | GT200500027A (enExample) |
| NL (1) | NL1028321C2 (enExample) |
| PA (1) | PA8624101A1 (enExample) |
| PE (1) | PE20050694A1 (enExample) |
| TW (1) | TW200528446A (enExample) |
| UY (1) | UY28750A1 (enExample) |
| WO (1) | WO2005082883A2 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7541357B2 (en) | 2004-07-15 | 2009-06-02 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| JP2009504759A (ja) * | 2005-08-16 | 2009-02-05 | メモリ ファーマセチカル コーポレーション | ホスホジエステラーゼ１０阻害剤 |
| JP2009527542A (ja) * | 2006-02-23 | 2009-07-30 | ファイザー・プロダクツ・インク | Ｐｄｅ１０阻害薬としての置換キナゾリン |
| JP2009528365A (ja) * | 2006-02-28 | 2009-08-06 | アムゲン インコーポレイティッド | ホスホジエステラーゼ１０阻害剤としてのシンノリン及びキナゾリン誘導体 |
| US20090099175A1 (en) * | 2006-03-01 | 2009-04-16 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
| US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| MX2008011257A (es) * | 2006-03-08 | 2008-09-25 | Amgen Inc | Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10. |
| EP2057153B1 (en) | 2006-07-10 | 2012-09-12 | H. Lundbeck A/S | (3-aryl-piperazin-1-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| JP2010527930A (ja) * | 2007-05-18 | 2010-08-19 | ワイス・エルエルシー | キナゾリン化合物 |
| US7858620B2 (en) | 2007-09-19 | 2010-12-28 | H. Lundbeck A/S | Cyanoisoquinoline |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| US8133897B2 (en) | 2008-06-20 | 2012-03-13 | H. Lundbeck A/S | Phenylimidazole derivatives as PDE10A enzyme inhibitors |
| TWI501965B (zh) * | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
| UA102693C2 (ru) * | 2008-06-20 | 2013-08-12 | Х. Луннбек А/С | Производные фенилимидазола как ингибиторы фермента pde10a |
| ES2446971T3 (es) * | 2009-05-12 | 2014-03-11 | Albany Molecular Research, Inc. | Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso |
| JP5739415B2 (ja) * | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用 |
| CA2760837C (en) * | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TWI481607B (zh) | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物 |
| TW201200516A (en) | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
| TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
| BR112012021198B1 (pt) | 2010-02-26 | 2021-12-14 | Mitsubishi Tanabe Pharma Corporation | Compostos de pirazolopirimidina, composições relacionadas e seu uso como inibidores de pde10 |
| TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
| TW201206935A (en) | 2010-07-16 | 2012-02-16 | Lundbeck & Co As H | Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor |
| DE102010042833B4 (de) | 2010-10-22 | 2018-11-08 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung |
| JO3089B1 (ar) | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
| SG192839A1 (en) | 2011-02-18 | 2013-09-30 | Allergan Inc | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| WO2013045607A1 (en) | 2011-09-30 | 2013-04-04 | H. Lundbeck A/S | Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
| WO2013050527A1 (en) | 2011-10-05 | 2013-04-11 | H. Lundbeck A/S | Quinazoline derivatives as pde10a enzyme inhibitors |
| TWI570124B (zh) | 2011-12-21 | 2017-02-11 | Ｈ 朗德貝克公司 | 作為ｐｄｅ１０ａ酵素抑制劑的喹啉衍生物 |
| WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| CA2902781C (en) | 2013-02-27 | 2020-12-29 | Mochida Pharmaceutical Co., Ltd. | Novel pyrazole derivative |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| WO2016064970A1 (en) * | 2014-10-22 | 2016-04-28 | The Board Of Regents Of The University Of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
| AU2020407600A1 (en) | 2019-12-18 | 2022-06-30 | Chdi Foundation, Inc. | Compounds and probes for imaging huntingtin protein |
| CA3180793A1 (en) * | 2020-06-05 | 2021-12-09 | George GARIBALDI | Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome |
| CN114456184B (zh) * | 2022-02-21 | 2023-08-22 | 南华大学附属第一医院 | 一种3-芳基异喹啉衍生物及其制备与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674791A (en) * | 1968-03-26 | 1972-07-04 | Marion Laboratories Inc | Benzamido 2 lower alkyl decahydroisoquinolines |
| PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| PE20030008A1 (es) * | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
-
2005
- 2005-02-07 CA CA002556413A patent/CA2556413A1/en not_active Abandoned
- 2005-02-07 EP EP05702449A patent/EP1723134A2/en not_active Withdrawn
- 2005-02-07 JP JP2006553698A patent/JP2007523152A/ja not_active Abandoned
- 2005-02-07 WO PCT/IB2005/000307 patent/WO2005082883A2/en not_active Ceased
- 2005-02-07 BR BRPI0507839-3A patent/BRPI0507839A/pt not_active IP Right Cessation
- 2005-02-15 PE PE2005000175A patent/PE20050694A1/es not_active Application Discontinuation
- 2005-02-16 UY UY28750A patent/UY28750A1/es not_active Application Discontinuation
- 2005-02-16 DO DO2005000022A patent/DOP2005000022A/es unknown
- 2005-02-17 NL NL1028321A patent/NL1028321C2/nl not_active IP Right Cessation
- 2005-02-17 GT GT200500027A patent/GT200500027A/es unknown
- 2005-02-17 AR ARP050100564A patent/AR047682A1/es unknown
- 2005-02-17 TW TW094104654A patent/TW200528446A/zh unknown
- 2005-02-18 US US11/062,133 patent/US7268142B2/en not_active Expired - Fee Related
- 2005-02-18 PA PA20058624101A patent/PA8624101A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL1028321C2 (nl) | 2006-05-23 |
| WO2005082883A2 (en) | 2005-09-09 |
| UY28750A1 (es) | 2005-09-30 |
| PE20050694A1 (es) | 2005-10-04 |
| TW200528446A (en) | 2005-09-01 |
| EP1723134A2 (en) | 2006-11-22 |
| BRPI0507839A (pt) | 2007-05-08 |
| AR047682A1 (es) | 2006-02-01 |
| CA2556413A1 (en) | 2005-09-09 |
| PA8624101A1 (es) | 2005-11-25 |
| DOP2005000022A (es) | 2005-08-30 |
| US20050182079A1 (en) | 2005-08-18 |
| NL1028321A1 (nl) | 2005-08-19 |
| US7268142B2 (en) | 2007-09-11 |
| WO2005082883A3 (en) | 2007-04-26 |
| JP2007523152A (ja) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200500027A (es) | Derivados de tetrahidroisoquinolinilo de quinazolina e isoquinolina | |
| GT200600342A (es) | Compuestos de cicloalquilo amino-hidantoina y uso de estos para la modulacion de beta-secretasa | |
| GT200400092A (es) | Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
| GT200500226A (es) | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa | |
| GT200400161A (es) | Piridinonas sustituidas | |
| GT200500101A (es) | Compuestos de metil-aril o heteroaril-amida sustituida | |
| GT200600024A (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
| GT200600197A (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
| GT200500242A (es) | Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas | |
| GT200500240A (es) | Nuevos herbicidas | |
| GT200600339A (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
| CY1112630T1 (el) | Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog | |
| GT200300289A (es) | Derivados de pirrolopirimidina | |
| BRPI0608886B8 (pt) | derivados de n-sulfonilpirróis e seus usos | |
| GT200200286A (es) | Nuevos derivados de pirido(2,1-a) isoquinolina | |
| GT200400107A (es) | Fungicidas | |
| GT200300101A (es) | Pirazolopiridinas substituidas con carbamato | |
| GT200500103A (es) | 4-fenilamino-quinazolin-6-il-amidas | |
| GT200300292A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
| CR9866A (es) | Novedosos derivados de 1-aza-bicicloalquilo para el tratamiento de trastornos psicoticos y neurodegenerativos | |
| GT200500097A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central | |
| GT200400050A (es) | Compuestos de quinolina y quinoxalina | |
| GT200200216A (es) | Derivados del 3-azabiciclo [3.1.0] hexano | |
| PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
| GT200400041A (es) | Derivados azabiciclicos de piridiloximetilo y bencisoxazol |